Cargando…

Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from a Phase III community-acquired bacterial pneumonia (CABP) trial

OBJECTIVES: To report Streptococcus pneumoniae serotyping and susceptibility data from a recent clinical trial (ML-3341-306) comparing delafloxacin with moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia (CABP). METHODS: Serotyping and susceptibility testing were con...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCurdy, S P, Sheets, A J, Cammarata, S K, Vidal, J E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210009/ https://www.ncbi.nlm.nih.gov/pubmed/34223119 http://dx.doi.org/10.1093/jacamr/dlab057

Ejemplares similares

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial
por: McCurdy, Sandra, et al.
Publicado: (2020)

2230. Analysis of the Microbiological Data from the Delafloxacin (DLX) Phase 3 Community-acquired Bacterial Pneumonia (CABP) Trial
por: McCurdy, Sandra, et al.
Publicado: (2019)

A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)
por: Horcajada, Juan P, et al.
Publicado: (2019)

2234. Outcomes by Age and Gender from a Global Phase 3 Study of Delafloxacin (DLX) in Community-Acquired Bacterial Pneumonia (CABP)
por: Madej, Andrzej, et al.
Publicado: (2019)

2232. A Global Phase 3 Study of Delafloxacin (DLX) Compared with Moxifloxacin (MOX) in Patients with Community-acquired Bacterial Pneumonia (CABP)
por: Salata, Robert, et al.
Publicado: (2019)

2228. Treatment of Community-Acquired Bacterial Pneumonia (CABP) in Patients with Diabetes: Outcomes from a Global Phase 3 Study of Delafloxacin (DLX)
por: Kaidashev, Igor, et al.
Publicado: (2019)

Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy
por: Di Pasquale, Marta, et al.
Publicado: (2017)

Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran
por: Habibian, Samira, et al.
Publicado: (2013)

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in the Philippines, 2012–2018
por: Sia, Sonia B., et al.
Publicado: (2021)

Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China
por: Pan, Fen, et al.
Publicado: (2015)

Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive Streptococcus pneumoniae in the nine-year period in Serbia
por: Opavski, Natasa, et al.
Publicado: (2023)

1307. Emerging Treatments in Ongoing Battle Against Community-Acquired Bacterial Pneumonia (CABP): The Positive Impact of Online Education
por: Hurst, Simi, et al.
Publicado: (2018)

Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae
por: Karcic, Emina, et al.
Publicado: (2015)

Revisitingmolecular serotyping of Streptococcus pneumoniae
por: Camargo, Dhian RA, et al.
Publicado: (2015)

Serotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012
por: Kim, Chung Jong, et al.
Publicado: (2016)

Streptococcus pneumoniae from Palestinian Nasopharyngeal Carriers: Serotype Distribution and Antimicrobial Resistance
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2013)

LB6. Oral Lefamulin Is Safe and Effective in the Treatment of Adults With Community-Acquired Bacterial Pneumonia (CABP): Results of Lefamulin Evaluation Against Pneumonia (LEAP 2) Study
por: Alexander, Elizabeth, et al.
Publicado: (2018)

In Vitro Activity of Lefamulin Against a Global Collection of Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP, SENTRY 2015)
por: Paukner, Susanne, et al.
Publicado: (2017)

Serotype Distribution and Antimicrobial Susceptibility of Streptococcus pneumoniae in Pre- and Post- PCV7/13 Eras, Taiwan, 2002–2018
por: Wu, Chi-Jung, et al.
Publicado: (2020)

Antibiotic prescribing by age, sex, race, and ethnicity for patients admitted to the hospital with community-acquired bacterial pneumonia (CABP) in the All of Us database
por: Gilmore, Corbyn M., et al.
Publicado: (2023)

Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries
por: Yahiaoui, Rachid Y., et al.
Publicado: (2018)

Emerging resistant serotypes of invasive Streptococcus pneumoniae
por: Elshafie, Sittana, et al.
Publicado: (2016)

Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae in Children Living in SAARC Countries: A Systematic Review
por: Jaiswal, Nishant, et al.
Publicado: (2014)

Serotype Distribution, Antimicrobial Susceptibility, and Multilocus Sequencing Type (MLST) of Streptococcus pneumoniae From Adults of Three Hospitals in Shanghai, China
por: Li, Xin-Xin, et al.
Publicado: (2019)

Antimicrobial Susceptibility Pattern and Serotype Distribution of Streptococcus pneumoniae Isolates From a Hospital-Based Study in Chandigarh, North India
por: Sharma, Swati, et al.
Publicado: (2022)

Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates in Tehran, Iran: A Surveillance Study
por: Habibi Ghahfarokhi, Soheila, et al.
Publicado: (2020)

Conformation and Cross-Protection in Group B Streptococcus Serotype III and Streptococcus pneumoniae Serotype 14: A Molecular Modeling Study
por: Kuttel, Michelle M., et al.
Publicado: (2019)

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in children with acute bacterial meningitis in Mozambique: implications for a national immunization strategy
por: Nhantumbo, Aquino Albino, et al.
Publicado: (2016)

2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study
por: Schranz, Jennifer, et al.
Publicado: (2019)

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes
por: Alexander, Elizabeth, et al.
Publicado: (2019)

Serotype Distribution and Drug Resistance in Streptococcus pneumoniae, Palestinian Territories
por: Kattan, Randa, et al.
Publicado: (2011)

Burden of Community-Acquired Pneumonia due to PCV-13 Streptococcus pneumoniae Serotypes Among Hospitalized Adults in the United States
por: Ramirez, Julio
Publicado: (2017)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

703. In Vitro Activity of Lefamulin Against Bacterial Pathogens Causing Community-Acquired Bacterial Pneumonia (CABP): SENTRY Surveillance 2017–2018 Results From the United States (US)
por: Sader, Helio S, et al.
Publicado: (2019)

Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique
por: Bos, Jeannet C, et al.
Publicado: (2014)

Serotype Competence and Penicillin Resistance in Streptococcus pneumoniae
por: Hsieh, Yu-Chia, et al.
Publicado: (2006)

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
por: Porter, Barbara D., et al.
Publicado: (2014)

Serotype Distribution, Antimicrobial Susceptibility, Multilocus Sequencing Type and Virulence of Invasive Streptococcus pneumoniae in China: A Six-Year Multicenter Study
por: Zhou, Menglan, et al.
Publicado: (2022)

1353. In Vitro Activity of Lefamulin (LEF) Against Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP): 2016 SENTRY Data From the United States
por: Paukner, Susanne, et al.
Publicado: (2018)

Serotypes and Antimicrobial Susceptibility of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children Less Than 5 Years Old in Egypt
por: El-Kholy, Amani, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6i2ce6f74fi9b4t66pfll9aq5